← Back to headlines
Immunic Closes $200M Private Placement for MS Trials
Immunic has closed a $200 million private placement to fund late-stage multiple sclerosis trials, securing significant capital for its research and development.
17 Feb, 21:33 — 17 Feb, 21:33
Sources
Showing 1 of 1 sources
Related Stories
Amazon's First Customer Receipt Goes Viral, Bezos and Musk React
just now
Farmers' Group Criticizes Proposed Pax Silica Economic Zone in Philippines
just now
Philippine President Marcos Orders P17.27 Billion for Classroom Construction
just now
Philippine President Marcos Pushes P46.22 Billion for Infrastructure Projects
just now